세계의 후성유전학 시장 및 기술

The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.

The global market for epigenetic biomarker-based IVDs is expected to grow from $1.9 billion in 2024 to $4.4 billion by the end of 2029, at a CAGR of 18.0% from 2024 through 2029.

The global market for epigenetics research tools and reagents is expected to grow from $1.8 billion in 2024 to $2.2 billion by the end of 2029, at a CAGR of 4.1% from 2024 through 2029.

Report Scope

This report comprehensively analyzes the global market for epigenetics products, research tools and reagents, epigenetic biomarker-based in vitro diagnostics (IVDs) and epigenetics-targeted therapeutics. It offers both quantitative and qualitative insights to help readers formulate growth strategies, evaluate the market landscape, assess their competitive positions and make informed business decisions regarding epigenetics products and services. The scope of epigenetics-targeted therapeutics includes DNA methyltransferase (DNMT) inhibitors, histone deacetylase (HDAC) inhibitors, isocitrate dehydrogenase (IDH) inhibitors and zeste homolog 2 (EZH2) inhibitors.

In this report, BCC Research estimated market data for 2023 (base year) and forecasts values for 2024 through 2029. The research tools and reagents market segmentation is based on the study methods. Epigenetic biomarker-based IVDs market segmentation is based on clinical indications. Epigenetics targeted therapeutics market segmentation is based on drug class. This report also provides regional analyses for epigenetics products.

This report analyzes industry growth drivers, restraints, trends and opportunities in the epigenetics market. The report also covers the competitive landscape and latest trends in epigenetics products. Emerging technologies that impact the epigenetics market are also discussed, along with current information about new products, acquisitions and collaborations related to the epigenetics market.

Report Includes

• 25 data tables and 66 additional tables
• Analyses of the trends in global markets for epigenetics technologies, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the size and growth forecasts of the global epigenomics market, and a corresponding market share analysis by product type, study method, clinical indication, drug class and region
• Facts and figures pertaining to the market dynamics, technological advancements, regulatory landscape, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Evaluation of recent patent activity and key granted and published patents in the industry
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Bristol-Myers Squibb Co., Les Laboratoires Servier, Exact Sciences Corp., Thermo Fisher Scientific Inc., and Qiagen

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Epigenetics Overview
• DNA Methylation
• Histone Modification
• RNA Modifications
• Epigenetic Modulators

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Rising Prevalence of Cancer and Unmet Need in Oncology
• Advances in Analytical Technologies and Tools
• Increasing Investment in Biomedical Research
• Trend Towards Precision Medicine
• Growing Interest in Liquid Biopsy
• Market Restraints
• From Bench to Bedside: The Translation Gap in Epigenetics
• Epigenetic Therapeutics: Limited Clinical Success Against Solid Tumors
• Stringent Regulatory Landscape
• Market Trends
• Combining Epigenetic Modifiers with Other Therapeutic Class
• Multi-omics Integration
• Long-Read Sequencing in Epigenetic Research
• Epigenetic Biomarkers-based Blood Test for Cancer Screening

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies
• Epigenome Editing
• Epitranscriptomics
• Bromodomain and Extra-Terminal Domain Inhibitors
• Menin Inhibitors
• Application Beyond Oncology
• Pipeline Analysis
• Overview
• Novel Epigenetic Therapeutics in Development in Phase 2 and Above

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Epigenetics Research Tools and Reagents Market, by Study Method
• Market Overview
• Market Size and Forecast
• DNA Methylation
• Histone Modification
• RNA Modification
• In Vitro Diagnostics (IVDs) Market, by Clinical Indication
• Market Overview
• Market Size and Forecast
• Epigenetic Therapeutics Market, by Drug Class
• Market Overview
• Market Size and Forecast
• Geographic Breakdown
• Epigenetics Research Tools and Reagents Market, by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Research Tools and Reagents
• In Vitro Diagnostics
• Therapeutics

Chapter 7 Sustainability in the Epigenetics Market: An ESG Perspective

• Introduction to ESG
• Key ESG Issues in Epigenetics Pharmaceuticals and Diagnostics Market
• Sustainability Practices in Pharmaceuticals Manufacturing
• Sustainable Packaging
• Key ESG Issues in Epigenetics Research Tools Market
• ESG Risk Ratings Score -- Understanding the Data
• Concluding Remarks

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ACTIVE MOTIF INC.
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRISTOL-MYERS SQUIBB CO.
• DAIICHI SANKYO CO. LTD.
• EXACT SCIENCES CORP.
• GUARDANT HEALTH
• HOLOGIC INC.
• LES LABORATOIRES SERVIER
• MERCK KGAA
• NUCLEIX
• PROMEGA CORP.
• QIAGEN
• REVVITY INC. (PERKINELMER)
• THERMO FISHER SCIENTIFIC INC.